Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Am J Surg Pathol. 2022 Jun 20:10.1097/PAS.0000000000001929. doi: 10.1097/PAS.0000000000001929

Table 3.

Immunohistochemical staining and NTRK fusions of the cohort.

Case Immunohistochemical stains NTRK fusion
Pan-TRK S100 CD34 Desmin
1 ND ND ND 0 C16orf72∷NTRK1
2 3 (D, C) 1 (F) POS 0 TPM3∷NTRK1
3 3 (D, C) ND ND 0 TPR∷NTRK1
4 2 (D, C) 0 ND 0 TPR∷NTRK1
5 ND POS POS 0 TPM3∷NTRK1
6 3 (D, C) 2 (MF) 3 (MF) 0 TPR∷NTRK1
7 1 (F, C) 2 (D) 2 (MF) 0 EML4∷NTRK3
8 2 (D, C) 0 0 0 TFG∷NTRK3
9 1 (P, N) 2 (MF) 0 0 Failed QC
10 2 (D, C) 3 (MF) 2 (MF) 0 SPECC1L∷NTRK3
11 3 (D, C) 1 (MF) 3 (MF) 0 TPM3∷NTRK1
12 2 (D, C) 3 (MF) 0 0 Insufficient tissue
13 2 (D, C) 3 (MF) 0 0 TPR∷NTRK1
14 3 (D, C) 2 (MF) ND 0 IRF2BP2∷NTRK1
15 3 (D, C) 2 (MF) ND ND TPM3∷NTRK1

0 = negative; 1 = weak; 2= moderate; 3= strong; F = focal; MF = multifocal; P = patchy; D = diffuse; C = cytoplasmic; N = nuclear; ND = not done; POS = positive by report (slides not available for review)